First Enhanced Equity Income Fund (FFA) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 4.7x for First Enhanced Equity Income Fund). abrdn Life Sciences Investors offers the higher dividend yield (10.88% vs 6.92%).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | FFA | HQL |
|---|---|---|
| Share price | $22.41 | $17.56 |
| Market cap | $447.93M | — |
| 1-day change | +0.72% | 0.00% |
| YTD return | — | +4.65% |
| 1-year return | — | +11.21% |
| 5-year return | — | -15.00% |
| P/E ratio (TTM) | 4.71 | 2.64 |
| EPS (TTM) | $4.76 | $6.64 |
| Dividend yield | 6.92% | 10.88% |
| Annual dividend | $1.55 | $1.91 |
| 52-week high | $23.82 | $22.67 |
| 52-week low | $19.50 | $15.66 |
| Distance from 52-week high | -5.92% | -22.54% |
| Average volume | 25.73K | 148.17K |
| Shares outstanding | 19.99M | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- First Enhanced Equity Income Fund trades at a higher earnings multiple (4.7x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.88% vs 6.92%).
FFA vs HQL FAQ
Which has the lower P/E ratio, FFA or HQL?
HQL has the lower trailing P/E at 2.6, versus 4.7 for FFA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, First Enhanced Equity Income Fund or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 10.88%, compared with 6.92% for First Enhanced Equity Income Fund.
Are First Enhanced Equity Income Fund and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.